Target intelligence / Profile preview

Nontypeable Haemophilus influenzae surface antigen (NTHi surface antigen)

Target
NTHi surface antigen
Molecular classification
Outer membrane protein, Bacterial adhesin, Glycolipid
01

Overview

Nontypeable Haemophilus influenzae surface antigens comprise diverse membrane-associated proteins (such as HMW1, HMW2, Hia, P5, and P6) and glycolipids (notably LOS) that mediate the bacteria’s adhesion to host respiratory epithelial cells, biofilm formation, and evasion of host immune defenses through mechanisms such as antigenic and phase variation. These surface molecules are major targets for the host immune system and are under investigation as candidates for vaccine development due to their roles in pathogenicity and immune recognition. However, a high degree of genetic and antigenic heterogeneity among these antigens poses significant challenges for developing broadly protective vaccines or therapeutic agents.

Other names
Outer membrane proteins of NTHisurface-exposed antigens of NTHi
02

Mechanism of action

Induction of protective antibody or T-cell responses (in vaccine development); Inhibition of adhesion or colonization (experimental)

03

Biological functions

Adhesion to host cellsEvasion of immune response (antigenic variation, serum resistance)Biofilm formationImmune recognition (antibody, Th17 cell responses)
04

Disease associations

Infection (notably otitis media, COPD, bronchitis, pneumonia)
05

Safety considerations

High antigenic variability among NTHi strains complicates universal vaccine development and reduces cross-strain immunityPhase variation and immune evasion limit long-term efficacy
06

Interacting drugs

No specific small molecule drugs are directly approved to target NTHi antigens; several are candidates for vaccine development or are experimental monoclonal antibodies
07

Biomarkers

Presence of specific antibodies (e.g., against HMW1/HMW2, P5, LOS)

Beyond the preview

Go deeper on Nontypeable Haemophilus influenzae surface antigen (NTHi surface antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nontypeable Haemophilus influenzae surface antigen (NTHi surface antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call